Persistent URL of this record https://hdl.handle.net/1887/106514
In Collections
This item can be found in the following collections:
![A phase 1/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancer](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
A phase 1/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancer
- All authors
- Dijkgraaf, E.M.; Santegoets, S.J.A.M.; Reyners, A.K.L.; Goedemans, R.; Nijman, H.W.; Poelgeest, M.I.E. van; Erkel, A.R. van; Smit, V.T.H.B.M.; Daemen, T.A.H.H.; Hoeven, J.J.M. van der; Melief, C.J.M.; Welters, M.J.P.; Kroep, J.R.; Burg, S.H. van der
- Date
- 2015-10-13
- Journal
- Oncotarget
- Volume
- 6
- Issue
- 31
- Pages
- 32228 - 32243